Skip to main content

Priveq invests in CSAM’s growth

Pressmeddelande   •   Maj 16, 2014 14:04 CEST

Priveq Investment Fund IV (”Priveq Investment”) will, through the holding company CSAM Invest AS, inject capital in CSAM Health AS (”CSAM”), a leading provider of software to healthcare providers in Norway and Sweden. The company’s founders and management will together with other employee shareholders maintain a majority ownership in the company, where Priveq’s injection of capital will provide CSAM with further opportunities to continue its successful expansion.

CSAM is a well-managed and profitable company that has experienced strong and profitable growth. The company offers software to healthcare providers in Norway, Sweden and the UK, with a focus within oncology and maternity treatment areas, as well as providing a platform that enables interaction between healthcare software solutions. The company was founded by the current CEO in 2007 and has exhibited a solid and profitable growth for the last four years, both organically and through acquisitions. For the fiscal year ending 2013, CSAM had sales of around 84 MNOK. CSAM’s head office is located in Oslo, Norway and the company has 70 employees in total.

“CSAM’s strong product offering within its niches combined with a strong customer base, creates a good foundation for continued growth. The company has a dedicated and strong group of employees and an offering that generates added value for both caregivers and patients. We look forward to being an active partner during the company’s exciting journey going forward”, says Louise Nilsson, Partner and Investment manager at Priveq Advisory AB, advisor to Priveq Investment.

“We are very pleased with having Priveq Investment as a new and active partner in CSAM. Priveq, along with its extensive experience from more than 100 growth companies and financial strength, is a perfect partner for CSAM in its continued growth.”, says Ansgar Gabrielsen, Chairman of CSAM Health AS.

Credit Suisse has advised CSAM in the process.

For further information, please contact:

Louise Nilsson, Partner and Investment Manager, Priveq Advisory ABMob: +46 709 50 95 50
louise.nilsson@priveq.se

Ansgar Gabrielsen, Chairman, CSAM Health AS
Tel. +47 97 97 27 33
ansgar.gabrielsen@csamhealth.com

Sverre Flatby, CEO, CSAM Health AS
Tel. +47 91 59 91 59
sverre.flatby@csamhealth.com

Kommentarer (0)

Lägg till kommentar

Kommentera